Skip to main content

Clinical trial C101

Open, non-controlled, multicenter, first-in-human study for the evaluation of the safety, pharmacokinetics and preliminary antitumor activity of GM102 in patients with advanced pretreated gynecological cancer

Organ Multiples
Trial status Trial closed
Trial type
Interventionnal with IMP
Phase Trial phase 1
Academic trial Non
Sponsor Gamamabs Pharma
EudraCT Identifier 2015-004252-22
Inclusion criteria Any line RECIST 1.1
Last update